Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 30

1.

Voucher-based reinforcement of opiate plus cocaine abstinence in treatment-resistant methadone patients: effects of reinforcer magnitude.

Dallery J, Silverman K, Chutuape MA, Bigelow GE, Stitzer ML.

Exp Clin Psychopharmacol. 2001 Aug;9(3):317-25.

PMID:
11534542
2.

[Heroin-assisted treatment of opiate dependent patients. Experiences from Swiss trials for medical prescription of narcotics (PROVE)].

Steffen T, Uchtenhagen A, Gutzwiller F, Dobler-Mikola A, Blättler R.

Internist (Berl). 1999 Jun;40(6):651-6. Review. German. No abstract available.

PMID:
10420321
3.

Voucher-based incentives. A substance abuse treatment innovation.

Higgins ST, Alessi SM, Dantona RL.

Addict Behav. 2002 Nov-Dec;27(6):887-910. Review.

PMID:
12369474
4.

Multimodal drug addiction treatment: a field comparison of methadone and buprenorphine among heroin- and cocaine-dependent patients.

Vigezzi P, Guglielmino L, Marzorati P, Silenzio R, De Chiara M, Corrado F, Cocchi L, Cozzolino E.

J Subst Abuse Treat. 2006 Jul;31(1):3-7. Review.

PMID:
16814005
5.

Rationale for maintenance pharmacotherapy of opiate dependence.

Kreek MJ.

Res Publ Assoc Res Nerv Ment Dis. 1992;70:205-30. Review.

PMID:
1346939
6.

Opiate treatments.

Johns A.

Addiction. 1994 Nov;89(11):1551-8. Review.

PMID:
7841870
7.

Opiate-dependent patients receiving methadone. How physicians should manage therapy.

Kahan M, Sutton N.

Can Fam Physician. 1996 Sep;42:1769-78. Review.

8.

Buprenorphine treatment of opiate and cocaine abuse: clinical and preclinical studies.

Mello NK, Mendelson JH, Lukas SE, Gastfriend DR, Teoh SK, Holman BL.

Harv Rev Psychiatry. 1993 Sep-Oct;1(3):168-83. Review.

PMID:
9384844
9.

Biological correlates of methadone maintenance pharmacotherapy.

Kreek MJ.

Ann Med Interne (Paris). 1994 Nov;145 Suppl 3:9-14. Review. No abstract available.

PMID:
7880038
10.

Leaving methadone treatment: lessons learned, lessons forgotten, lessons ignored.

Magura S, Rosenblum A.

Mt Sinai J Med. 2001 Jan;68(1):62-74. Review.

PMID:
11135508
11.

[Special problems of HIV-positive women who are either drug abusers or on methadone replacement therapy].

Isernhagen K.

Zentralbl Gynakol. 1999;121(11):555-7. Review. German. No abstract available.

PMID:
10612228
12.

[Methadone maintenance as a therapeutic approach in the treatment of opiate dependent patients].

Scherbaum N, Gastpar M.

Nervenarzt. 1991 Sep;62(9):529-35. Review. German.

PMID:
1956472
13.

Obtaining follow-up interviews for treatment evaluation.

Desmond DP, Maddux JF, Johnson TH, Confer BA.

J Subst Abuse Treat. 1995 Mar-Apr;12(2):95-102. Review.

PMID:
7623396
14.

Effects of in-utero opiate exposure: new paradigms for old questions.

Kaltenbach KA.

Drug Alcohol Depend. 1994 Oct;36(2):83-7. Review.

PMID:
7851284
15.

[Opiate addiction as a chronic brain disease: new concept of an old problem, and re-evaluation of methadone treatment].

Bleich A, Adelson M.

Harefuah. 2000 Mar 15;138(6):454-7. Review. Hebrew. No abstract available.

PMID:
10883159
16.

Contingency management for treatment of substance abuse.

Stitzer M, Petry N.

Annu Rev Clin Psychol. 2006;2:411-34. Review.

PMID:
17716077
17.

Pregnancy and injecting drug use.

Bell J, Harvey-Dodds L.

BMJ. 2008 Jun 7;336(7656):1303-5. doi: 10.1136/bmj.39514.554375.AE. Review. No abstract available.

18.

Cocaine abuse in methadone maintenance programs: integrating pharmacotherapy with psychosocial interventions.

Avants SK, Margolin A, Kosten TR.

J Psychoactive Drugs. 1994 Apr-Jun;26(2):137-46. Review.

PMID:
7931858
19.

[Contingency management in opioid substitution treatment].

Specka M, Böning A, Scherbaum N.

Fortschr Neurol Psychiatr. 2011 Jul;79(7):395-403. doi: 10.1055/s-0029-1245810. Epub 2010 Nov 24. Review. German.

PMID:
21108163
20.

Supplemental Content

Support Center